Central China New Life Ltd. (9983) AI Stock Analysis

• Market Cap: HK$1.17B
• Dividend Yield: 11.71%
• Average Volume (3M): 433.23K
• Price to Earnings (P/E): 5.0
• Beta (1Y): 0.76
• Revenue Growth: -2.61%
• EPS Growth: N/A
• Country: HK
• Employees: 5,699
• Sector: Real Estate
• Sector Strength: 53
• Industry: Real Estate - Services
• EPS (TTM): 0.09
• Shares Outstanding: 1,299,276,000
• 10 Day Avg. Volume: 384,600
• 30 Day Avg. Volume: 433,229
• PEG Ratio: -0.05
• Price to Book (P/B): 0.79
• Price to Sales (P/S): 0.50
• P/FCF Ratio: -324.26
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 61 Neutral
• Price Target: HK$1.00 ▲(9.89% Upside)

The stock's overall score is primarily influenced by its strong valuation, offering a low P/E ratio and high dividend yield. However, financial performance is mixed, with profitability recovery offset by weak cash flows. Technical indicators suggest bearish momentum, which is a concern for short-term price movements.

Central China New Life Ltd. Business Overview & Revenue Model

Company Description

Central China New Life Limited, an investment holding company, provides property management services and value-added services in the People's Republic of China. It operates through three segments: Property Management and Value-Added Services, Lifestyle Services, and Commercial Property Management and Consultation Services. The company manages a portfolio of properties, including residential properties, shopping malls, cultural tourism complexes, commercial apartments, office buildings, schools, hospitals, city services, factories, and parks and properties of governmental agencies. It also offers consultancy services to property developers, community value-added services, intelligent community services, personalized services to VIPs of the Central China Consumer Club, and real estate marketing services. In addition, the company operates Jianye + platform, an online to offline one-stop service platform that provides customers with goods and services; and offers travel services, as well as management services in Cuisine Henan Foodcourts. Further, it engages in the provision of hotel management and operation services; and management services for agricultural and cultural tourism projects, as well as in the commercial real-estate operations. The company was founded in 1994 and is based in Zhengzhou, the People's Republic of China. Central China New Life Limited is a subsidiary of Enjoy Start Limited.

How the Company Makes Money

Central China New Life Ltd. generates revenue through its diversified business model which includes three main streams: property management services, value-added services, and commercial operational services. Property management services, which include cleaning, security, gardening, and repair services, form the backbone of its revenue. In addition to these, the company offers value-added services such as home decoration, community living services, and online retail services to residents, which contribute significantly to its income. Commercial operational services, which involve managing shopping malls, office buildings, and other commercial properties, also play a crucial role in revenue generation. Strategic partnerships with property developers and a broad client base further bolster the company's earnings.

Central China New Life Ltd. Financial Statement Overview

Summary

The company shows signs of recovery in profitability with improved net profit and EBIT margins. However, the cash flow position is weak, with zero operating and free cash flow, raising liquidity concerns. The balance sheet is strong with low leverage, but a decrease in stockholders' equity is noted.

Income Statement

The company experienced fluctuating revenues with a decline in 2024 from 2022, but shows a recovery from 2023. Gross Profit Margin was 22.11% in 2024, showing a decrease from the previous year. The Net Profit Margin improved significantly to 7.27% in 2024 from a negative margin in 2023, indicating recovering profitability. EBIT and EBITDA margins have improved from negative figures in 2023 to 12.19% and 13.43% respectively in 2024.

Balance Sheet

The company maintains a strong equity base with an Equity Ratio of 39.41% in 2024. The Debt-to-Equity Ratio is low at 0.04, suggesting low leverage. However, Stockholders' Equity has decreased from 2023 to 2024. Return on Equity improved to 11.52% in 2024, reflecting better utilization of equity compared to losses in 2023.

Cash Flow

The cash flow position weakened with zero operating cash flow and free cash flow in 2024, down from negative figures in 2023. The absence of positive cash flows indicates potential liquidity issues. Without operating cash flow, the ability to generate cash from operations is a concern.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.90B	2.95B	2.84B	3.15B	3.60B	2.65B
Gross Profit	618.71M	652.77M	757.09M	1.04B	1.18B	860.72M
EBITDA	357.20M	396.59M	-641.15M	830.62M	887.44M	584.09M
Net Income	217.37M	214.59M	-574.37M	562.26M	619.56M	426.59M
Balance Sheet
Total Assets	4.45B	4.73B	4.85B	5.33B	5.04B	4.25B
Cash, Cash Equivalents and Short-Term Investments	835.61M	1.19B	1.66B	2.08B	2.32B	2.68B
Total Debt	65.34M	66.96M	67.84M	85.80M	50.18M	21.21M
Total Liabilities	2.44B	2.74B	2.69B	2.28B	1.98B	1.53B
Stockholders Equity	1.89B	1.86B	2.05B	2.94B	2.95B	2.69B
Cash Flow
Free Cash Flow	-780.48M	-4.53M	-89.89M	290.92M	145.45M	257.20M
Operating Cash Flow	-766.36M	3.86M	-77.09M	308.66M	178.44M	281.27M
Investing Cash Flow	-5.74M	893.00K	18.46M	126.84M	245.64M	-532.82M
Financing Cash Flow	-434.22M	-429.37M	-370.14M	-675.63M	-360.51M	2.00B

Central China New Life Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.91
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:9983, the sentiment is Negative. The current price of 0.91 is below the 20-day moving average (MA) of 0.95, below the 50-day MA of 1.00, and below the 200-day MA of 1.07, indicating a bearish trend. The MACD of -0.03 indicates Negative momentum. The RSI at 39.91 is Neutral, neither overbought nor oversold. The STOCH value of 51.39 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:9983.

Central China New Life Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3658	78 Outperform	HK$1.62B	6.51	18.19%	9.56%	10.09%	2.39%
6989	66 Neutral	HK$1.31B	4.17	7.55%	13.40%	-0.79%	-3.46%
Sector *	65 Neutral	$2.17B	12.19	3.79%	4.94%	3.15%	1.96%
9983	61 Neutral	HK$1.17B	4.98	11.48%	11.71%	-2.61%	―
6093	59 Neutral	HK$358.40M	18.44	2.59%	―	3.93%	-71.60%
0021	48 Neutral	HK$389.57M	28.14	-4.27%	―	1303.01%	-45.00%

Central China New Life Ltd. Corporate Events

Central China New Life Ltd. Updates Interim Dividend Payment Date

Central China New Life Ltd. has announced an update regarding its interim cash dividend for the six months ending June 30, 2025. The company declared an ordinary interim dividend of HKD 0.033 per share, with the payment date delayed to October 23, 2025. This announcement may affect shareholder expectations and financial planning due to the change in the dividend payment schedule.

The most recent analyst rating on (HK:9983) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Central China New Life Ltd. stock, see the HK:9983 Stock Forecast page.

Central China New Life Ltd. Updates Interim Dividend Payment Date

Central China New Life Ltd. has announced an update regarding its interim dividend for the six months ending June 30, 2025. The company has declared a dividend of HKD 0.033 per share, with the payment date delayed to October 23, 2025. This update may affect shareholders’ expectations and financial planning, as the delay in dividend payment could impact cash flow considerations for stakeholders.

The most recent analyst rating on (HK:9983) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Central China New Life Ltd. stock, see the HK:9983 Stock Forecast page.

Central China New Life Ltd. Reports Stable Interim Results Amid Revenue Dip

Central China New Life Ltd. reported its interim results for the six months ending June 30, 2025, showing a slight decrease in revenue by 3.3% to RMB1,433.8 million compared to the same period in 2024. Despite the revenue drop, the company’s net profit increased by 2.8% to RMB112.2 million, and the board has recommended an interim dividend of HK$3.3 cents per share, indicating stable financial performance and shareholder returns.

The most recent analyst rating on (HK:9983) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Central China New Life Ltd. stock, see the HK:9983 Stock Forecast page.

Central China New Life Ltd. Declares Interim Dividend for 2025

Central China New Life Ltd. has announced an interim cash dividend of HKD 0.033 per share for the six months ending June 30, 2025, with the payment date set for October 16, 2025. This announcement reflects the company’s ongoing commitment to delivering shareholder value and may impact its financial positioning and attractiveness to investors.

The most recent analyst rating on (HK:9983) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Central China New Life Ltd. stock, see the HK:9983 Stock Forecast page.

Central China New Life Announces Details of 2023 Share Award Scheme

Central China New Life Limited has announced additional details regarding its 2023 Share Award Scheme, which involved the conditional granting of 21,800,000 shares that became unconditional in August 2023. This scheme represents approximately 8.16% of the total shares in issue, highlighting the company’s efforts to incentivize and retain talent, potentially impacting its operational efficiency and market position.

The most recent analyst rating on (HK:9983) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Central China New Life Ltd. stock, see the HK:9983 Stock Forecast page.

Central China New Life Ltd. Announces Upcoming Board Meeting for Interim Results

Central China New Life Ltd. has announced that its board of directors will meet on August 26, 2025, to consider and approve the company’s unaudited interim results for the first half of the year and discuss the potential payment of an interim dividend. This meeting could have implications for the company’s financial outlook and investor relations, as it may influence dividend distributions and provide insights into the company’s performance during the first half of 2025.